We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.67B
AUM Growth
-$254M
Cap. Flow
-$364M
Cap. Flow %
-21.79%
Top 10 Hldgs %
25.94%
Holding
1,700
New
415
Increased
295
Reduced
305
Closed
556

Top Buys

Rank Stock Value
1
LI icon
Li Auto
LI
+$27.8M
2
JD icon
JD.com
JD
+$15.5M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$8.8M
4
CSIQ icon
Canadian Solar
CSIQ
+$8.72M
5
TCOM icon
Trip.com Group
TCOM
+$7.62M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$21.4M
2
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$14.6M
3
BEKE icon
KE Holdings
BEKE
+$14M
4
STOR
STORE Capital Corporation
STOR
+$12.4M
5
ONEM
1Life Healthcare
ONEM
+$12.1M

Sector Composition

Rank Sector Weight
1 Technology 13.68%
2 Consumer Discretionary 12.97%
3 Financials 12.73%
4 Industrials 9.28%
5 Healthcare 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELVN icon
1001
Enliven Therapeutics
ELVN
$4.35B
$40K ﹤0.01%
34,062
+18,776
+123% +$382K
SLAMW
1002
DELISTED
Slam Corp. warrant
SLAMW
$39.9K ﹤0.01%
173,366
– –
SYRS
1003
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$39.8K ﹤0.01%
14,899
+500
+3% +$1.94K
DFTX
1004
Definium Therapeutics
DFTX
$5.99B
$39.3K ﹤0.01%
12,400
-25,800
-68% -$85.8K
NAUT icon
1005
Nautilus Biotechnolgy
NAUT
$110M
$38.6K ﹤0.01%
13,944
-3,400
-20% -$7.13K
FIP icon
1006
FTAI Infrastructure
FIP
$508M
$38.3K ﹤0.01%
12,781
-18,900
-60% -$57.5K
NRGV icon
1007
Energy Vault
NRGV
$605M
$38.1K ﹤0.01%
+17,812
New +$60.7K
RLMD icon
1008
Relmada Therapeutics
RLMD
$484M
$37.7K ﹤0.01%
+16,700
New +$57.6K
PAYS icon
1009
Paysign
PAYS
$707M
$37.6K ﹤0.01%
10,368
-5,600
-35% -$19.1K
SRZN icon
1010
Surrozen
SRZN
$295M
$37.1K ﹤0.01%
4,113
– –
NFYS.WS
1011
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$36.8K ﹤0.01%
306,250
– –
SES icon
1012
SES AI
SES
$196M
$35K ﹤0.01%
+11,852
New +$37.4K
KRON
1013
DELISTED
Kronos Bio
KRON
$34.7K ﹤0.01%
23,744
+3,334
+16% +$6.39K
BCAB icon
1014
BioAtla
BCAB
$5.76M
$34.4K ﹤0.01%
257
-66
-20% -$11.9K
QSI icon
1015
Quantum-Si Incorporated
QSI
$172M
$34.1K ﹤0.01%
19,347
+7,213
+59% +$14.2K
CERS icon
1016
Cerus
CERS
$508M
$33.6K ﹤0.01%
11,304
+764
+7% +$2.3K
OSI.WS
1017
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$33.1K ﹤0.01%
275,000
– –
FXLV
1018
DELISTED
F45 Training Holdings Inc.
FXLV
$31.2K ﹤0.01%
26,922
– –
IVVD icon
1019
Invivyd
IVVD
$198M
$30.4K ﹤0.01%
+25,308
New +$46.2K
MCAGR
1020
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$28.8K ﹤0.01%
125,000
– –
GRTS
1021
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$28.3K ﹤0.01%
+10,169
New +$29.1K
OPEN icon
1022
Opendoor
OPEN
$3.38B
$25.5K ﹤0.01%
+14,952
New +$24.6K
RXT icon
1023
Rackspace Technology
RXT
$1.2B
$25.3K ﹤0.01%
13,457
-181
-1% -$465
LCTX icon
1024
Lineage Cell Therapeutics
LCTX
$286M
$25K ﹤0.01%
+16,688
New +$23.3K
KLTR icon
1025
Kaltura
KLTR
$250M
$24.9K ﹤0.01%
+12,984
New +$25.5K
39 40
41
42 43

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Prelude Capital Management held 1,700 positions worth $1.67B, down 13% from $1.92B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Prelude Capital Management withdrew a net $364M in Q1 2023, closing 556 positions and reducing 305 holdings. Its most notable exit was STORE Capital Corporation, an estimated $12.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Prelude Capital Management opened a new position in Li Auto worth $29.4M.

  • Prelude Capital Management's largest Q1 2023 buy was Li Auto: 1,178,041 shares worth $29.4M.
  • Prelude Capital Management added most to JD.com in Q1 2023, an estimated $15.5M increase.
  • Prelude Capital Management's biggest Q1 2023 reduction was Alibaba, cutting an estimated $21.4M.
  • Prelude Capital Management fully exited STORE Capital Corporation in Q1 2023, selling an estimated $12.4M.
  • Prelude Capital Management's ten largest holdings make up 26% of its $1.67B portfolio in Q1 2023.
  • Prelude Capital Management opened 415 new positions and closed 556 in Q1 2023.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.67B.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.